MASPX
Price
$29.50
Change
-$0.18 (-0.61%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

MASPX vs VMCPX

Header iconMASPX vs VMCPX Comparison
Open Charts MASPX vs VMCPXBanner chart's image
BlackRock Advantage SMID Cap Instl
Price$29.50
Change-$0.18 (-0.61%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MASPX vs VMCPX Comparison Chart
Loading...
VS
MASPX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MASPX is a StrongBuy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. MASPX (432M). VMCPX pays higher dividends than MASPX: VMCPX (1.51) vs MASPX (0.88). MASPX was incepted earlier than VMCPX: MASPX (46 years) vs VMCPX (14 years). MASPX is a more actively managed with annual turnover of: 125.00 vs. VMCPX (13.00). MASPX has a lower initial minimum investment than VMCPX: MASPX (2000000) vs VMCPX (100000000). MASPX (26.36) and VMCPX (25.17) have marching annual gain over last year. VMCPX return over 5 years is better than : 56.93 vs. MASPX (8.90).
MASPXVMCPXMASPX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence46 years14 years-
Gain YTD10.57012.59384%
Front LoadN/AN/A-
Min. Initial Investment20000001000000002%
Min. Initial Investment IRAN/AN/A-
Net Assets432M172B0%
Annual Yield % from dividends0.881.5158%
Returns for 1 year26.3625.17105%
Returns for 3 years9.449.8596%
Returns for 5 years8.9056.9316%
Returns for 10 years8.24128.756%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHR3.060.01
+0.33%
Archer Aviation
SBT4.64-0.02
-0.43%
Sterling Bancorp
EBAY62.75-0.47
-0.74%
eBay
CNXC63.38-0.79
-1.23%
Concentrix Corp
NRBO3.19-0.07
-2.15%
NeuroBo Pharmaceuticals